the total amount paid out in critical illness claims was £75.19m, with cancer accounting for 74 per cent of claims from women, mainly breast cancer, alongside 51 per cent from men.
.
.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
corinna's twin boys -- maarten, left, and linus -- were the first humans to be treated for their genetic disorder while still inside the womb.
.one woman's migraine story
.
.